证券记录 · 已归档季度
CPRX
Catalyst Pharmaceuticals, Inc. · Healthcare · Biotechnology
13被追踪持有人
-1Δ持有人
14.99M持有股份
$363.56M报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -7.1% ·
股份流向 -0.4% ·
净新建仓位 -7.7%
— 公式
广泛派发 — 持股数量下降且持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q1 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 109 | -4 | 77.02M | $2.42B | +12 | −16 |
| Q1 2026 | 116 | +4 | 78.68M | $1.95B | +8 | −4 |
| Q4 2025 | 111 | 0 | 78.17M | $1.82B | — | — |
| Q3 2025 | 19 | 0 | 48.11M | $947.78M | — | −1 |
| Q2 2025 | 17 | +1 | 43.29M | $939.35M | +1 | — |
| Q1 2025 | 13 | -1 | 14.99M | $363.56M | — | −1 |
| Q4 2024 | 14 | 0 | 15.06M | $314.25M | +1 | −1 |
| Q3 2024 | 13 | +3 | 9.07M | $180.23M | +4 | −1 |
| Q2 2024 | 10 | — | 9.29M | $143.84M | — | — |
持有人 · Q1 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 5.53M | -4.6% | $134.11M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 2.96M | +9.2% | $71.69M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 2.77M | +3.8% | $67.08M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 2.77M | +3.8% | $67.08M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Arrowstreet Capital ✦ | 1.04M | +48.2% | $25.10M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 977.62K | -19.6% | $23.71M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 977.62K | -19.6% | $23.71M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 685.42K | +57.0% | $16.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 685.42K | +57.0% | $16.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 445.51K | -6.6% | $10.80M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 445.51K | -6.6% | $10.80M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 445.51K | -6.6% | $10.80M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 445.51K | -6.6% | $10.80M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 445.51K | -6.6% | $10.80M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Millennium Management ✦ | 303.53K | -41.7% | $7.36M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 100.39K | +452.4% | $2.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Fisher Asset Management ✦ | 82.17K | -5.4% | $1.99M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | Wellington Management ✦ | 48.45K | -6.0% | $1.17M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Wellington Management ✦ | 48.45K | -6.0% | $1.17M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 48.45K | -6.0% | $1.17M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 48.45K | -6.0% | $1.17M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Gotham Asset Management ✦ | 47.31K | +21.4% | $1.15M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | Norges Bank ✦ (被动) | 13.77K | -85.0% | $333,826 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Marshall Wace | $5.29M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 378 持有人, 103.75M 股份, $2.50B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q1 2025 ·
方法论 ·
通过API获取此数据